XML 23 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Accumulated Other Comprehensive loss
Balance beginning (in shares) at Dec. 31, 2022   143,034,225      
Balance beginning at Dec. 31, 2022 $ 376,905 $ 14 $ 371,072 $ 21,772 $ (15,953)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued upon exercise of stock options (in shares)   959,143      
Common stock issued upon exercise of stock options 146   146    
Vested common stock awards (in shares)   1,713,163      
Vested common stock awards 1 $ 1      
Stock-based compensation 11,636   11,636    
Net (loss) income 23,798     23,798  
Other comprehensive income (loss) 10,021       10,021
Ending balance (in shares) at Dec. 31, 2023   145,706,531      
Ending balance at Dec. 31, 2023 422,507 $ 15 382,854 45,570 (5,932)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued upon exercise of stock options (in shares)   1,074,085      
Common stock issued upon exercise of stock options 252   252    
Vested common stock awards (in shares)   3,293,611      
Sponsor vesting shares forfeited (in shares)   (1,500,000)      
Stock-based compensation 10,080   10,080    
Net (loss) income (83,697)     (83,697)  
Other comprehensive income (loss) (10,777)       (10,777)
Ending balance (in shares) at Dec. 31, 2024   148,574,227      
Ending balance at Dec. 31, 2024 $ 338,365 $ 15 $ 393,186 $ (38,127) $ (16,709)